The storied success of sildenafil has undeniably shaped the healthcare landscape. However, investing in companies heavily dependent on generic versions and the waning patent protection surrounding this https://socialmediatotal.com/story6443810/the-blue-pill-and-pharmaceutical-companies-a-risky-venture